15.00
-0.3301(-2.15%)
Currency In USD
| Previous Close | 15.33 |
| Open | 15.22 |
| Day High | 15.29 |
| Day Low | 14.82 |
| 52-Week High | 17.49 |
| 52-Week Low | 7 |
| Volume | 28,518 |
| Average Volume | 109,404 |
| Market Cap | 309.83M |
| PE | -3 |
| EPS | -5 |
| Moving Average 50 Days | 15.64 |
| Moving Average 200 Days | 11.83 |
| Change | -0.35 |
If you invested $1000 in Amarin Corporation plc (AMRN) 10 years ago, it would be worth $314.71 as of September 08, 2025 at a share price of $14.98. Whereas If you bought $1000 worth of Amarin Corporation plc (AMRN) shares 5 years ago, it would be worth $172.18 as of September 08, 2025 at a share price of $14.98.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
GlobeNewswire Inc.
Aug 31, 2025 12:30 PM GMT
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action --DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 31, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted in vitro data assessing the
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
GlobeNewswire Inc.
Aug 30, 2025 12:30 PM GMT
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or Very High-Risk Patients Based on REDUCE-IT -- DUBLIN and BRIDGEWATER, N.J., Aug. 30, 2025 (GLOBE NEWSWIRE) --
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
GlobeNewswire Inc.
Aug 25, 2025 12:00 PM GMT
DUBLIN and BRIDGEWATER, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2025, August 29th-September 1st, in Madrid, Spain, wh